COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 1874: Articles 18731-18740  | Next

Bronchoscopy in COVID19 ARDS patients on mechanical ventilation: a prospective study
Mehta, R. M., Bansal, S., Kumar, A., Thorbole, A., L, C., Kalpakam, H.
10.1101/2021.02.02.21250362 — Posted: 2021-02-05
Arabic validation and cross-cultural adaptation of the 5C scale for assessment of COVID-19 vaccines psychological antecedents
Abd ElHafeez, S., Shaaban, R., Elbarazi, I., ElMakhzangy, R., Aly, M. O., Alnagar, A., Yacoub, M. Y., M. El Saeh, H., Eltaweel, N., Alqutub, S. T., Ghazy, R.
10.1101/2021.02.03.21251059 — Posted: 2021-02-05
Impact of systemic corticosteroids on hospitalized patients with COVID-19: January 2021 Meta-analysis of randomized controlled trials
Robinson, R., Prakash, V., Al Tamimi, R., Albast, N., Al-Bast, B.
10.1101/2021.02.03.21251065 — Posted: 2021-02-05
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
Cohen, C. A., Li, A. P., Hachim, A., Hui, D. S., Kwan, M. Y., Tsang, O. T., Chiu, S. S., Chan, W. H., Yau, Y. S., Kavian, N., Ma, F. N., Lau, E. H., Cheng, S. M., Poon, L. L., Peiris, M. J., Valkenburg, S. A.
10.1101/2021.02.02.21250988 — Posted: 2021-02-05
Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant
Edara, V. V., Floyd, K., Lai, L., Gardner, M., Hudson, W., Piantadosi, A., Waggoner, J., Babiker, A., Ahmed, R., Xie, X., Lokugamage, K., Menachery, V., Shi, P.-Y., COVID-19 Neutralization Study Group, , Suthar, M. S.
10.1101/2021.02.02.21250799 — Posted: 2021-02-05
IgA autoantibodies target pulmonary surfactant in patients with severe COVID-19
Sinnberg, T., Lichtensteiger, C., Hasan Ali, O., Pop, O. T., Gilardi, M., Risch, L., Bomze, D., Kohler, P., Vernazza, P., Albrich, W. C., Kahlert, C. R., Brugger, S. D., Abdou, M.-T., Zinnber, C., Tzankov, A., Roecken, M., Kern, L., Brutsche, M. H., Kalbacher, H., Velic, A., Macek, B., Penninger, J. M., Matter, M. S., Flatz, L.
10.1101/2021.02.02.21250940 — Posted: 2021-02-05
Antibody responses boosted in seropositive healthcare workers after single dose of SARS-CoV-2 mRNA vaccine
Bradley, T., CODIEFY study team, , Grundberg, E., Selvarangan, R.
10.1101/2021.02.03.21251078 — Posted: 2021-02-05
Increased SAR-CoV-2 shedding associated with reduced disease severity despite continually emerging genetic variants
Tang, C. Y., Wang, Y., Gao, C., Smith, D. R., McElroy, J. A., Li, T., Segovia, K., Haynes, T., Hammer, R., Sampson, C., Ritter, D., Schulze, C., Trotman, R., Lidl, G. M., Webby, R., Hang, J., Wan, X.-F.
10.1101/2021.02.03.21250928 — Posted: 2021-02-05
Risk Factors for Infection and Health Impacts of the COVID-19 Pandemic in People with Autoimmune Diseases
Fitzgerald, K. C., Mecoli, C. A., Douglas, M., Harris, S., Aravidis, B., Albayda, J., Hoke, A., Sotirchos, E. S., Orbai, A.-M., Petri, M., Christopher-Stine, L., Baer, A. N., Paik, J. J., Adler, B. L., Tiniakou, E., Timlin, H., Bhargava, P., Newsome, S. D., Venkatesan, A., Chaudhry, V., Lloyd, T. E., Pardo, C. A., Stern, B. J., Lazarev, M., Truta, B., Saidha, S., Chen, E. S., Sharp, M., Gilotra, N., Kasper, E. K., Gelber, A. C., Bingham, C. O., Shah, A. A., Mowry, E. M.
10.1101/2021.02.03.21251069 — Posted: 2021-02-05
Age-related heterogeneity in Neutralising antibody responses to SARS-CoV-2 following BNT162b2 vaccination
Collier, D., Ferreira, I., Datir, R., Meng, B., Bergamaschi, L., The CITIID-NIHR Bioresource COVID-19 Collaboration, , Elmer, A., Kingston, N., Graves, B., Graves, B., Smith, K. G., Bradley, J., Lyons, P., Ceron-Gutierrez, L., Barcenas-Morales, G., Doffinger, R., Wills, M., Gupta, R. K.
10.1101/2021.02.03.21251054 — Posted: 2021-02-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).